Non-traditional gene fusions in luminal breast cancer: A new target for therapy

FHS
August 22, 2023
12:11 am

A new editorial paper was published in Oncotarget’s Volume 14 on June 12, 2023, entitled, “Are cis-spliced fusion proteins pathological in more aggressive luminal breast cancer?”

Partnership with Microsaic Systems for Optimer-enabled water monitoring

New binders will be developed to multiple waterborne pathogens. Optimer will support continuous water monitoring for rapid detection.

June 14, 2024

What are the potential long-term effects on healthcare and the economy due to decreased STEMI treatment during the COVID-19 pandemic?

Researchers predicted long-term health consequences and expenses associated with ST-elevation myocardial infarction (STEMI) treatment during the first COVID-19 lockdown.

June 20, 2023

Women’s chronic care startup Allara raises $10M to expand nationwide

Allara, a startup focused on connecting women with chronic hormonal conditions to care, raised $10 million in Series A funding to expand its care coverage

October 19, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.